Concepedia

Karl-Ulrich Dobberstein

KD

Statistics

Publications

6

Citations

266

H-Index

6

Active since

1995

Affiliations

Martin Luther University Halle-Wittenberg(Current)

Massachusetts General Hospital

Heinrich Heine University Düsseldorf

Karl-Ulrich Dobberstein is an author at Martin Luther University Halle-Wittenberg specializing in oncology, molecular oncology, and glioblastoma.

Publications per year

1995–2003

6

Publications

6

Prognostic factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival

Nikolai G. Rainov, Karl-Ulrich Dobberstein, Hannes Bahn et al. · Journal of Neuro-Oncology · 1997 · 97 citations

Medicine, Molecular Genetics, Oncology +16

New Prodrug Activation Gene Therapy for Cancer Using Cytochrome P450 4B1 and 2-Aminoanthracene/4-Ipomeanol

Nikolai G. Rainov, Karl-Ulrich Dobberstein, Miguel Sena‐Esteves et al. · Human Gene Therapy · 1998 · 77 citations

Medicine, Oncology, Pharmacology +15

Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: Applications for prodrug-activating gene therapy

Sabine Steffens, Susanne Frank, Ute Fischer et al. · Cancer Gene Therapy · 2000 · 28 citations

Life Sciences, Biotechnology, Molecular Biology +16

A Chimeric Fusion Protein of Cytochrome CYP4B1 and Green Fluorescent Protein for Detection of Pro-Drug Activating Gene Delivery and for Gene Therapy in Malignant Glioma

Nikolai G. Rainov, Miguel Sena‐Esteves, Cornel Fraefel et al. · Advances in experimental medicine and biology · 1998 · 25 citations

Medicine, Oncology, Pharmacology +17

Absence of p53 autoantibodies in sera from glioma patients.

N. G. Rainov, Karl-Ulrich Dobberstein, Marina Fittkau et al. · PubMed · 1995 · 24 citations

Life Sciences, Immunology, Oncology +17

1–5 of 6